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Summary 
The phenotypic similarities between natural killer (NK) and T cells have led to the hypothesis 
that these distinctive lymphocyte subsets  may be developmentally related and thus may share 
a common progenitor (Lanier, L. L., H. Spits, and J. H. Phillips.  1992. Immunol.  Today. 13:392; 
Rodewald, H.-R., P. Moingeon, J. L. Lurich, C. Dosiou, P. Lopez, and E. L. Reinherz. 1992. 
Cell. 69:139).  In this report, we have investigated the potential of human CD34 + triple negative 
thymocytes ([TN] CD3 -, CD4-,  CD8-) to generate both T cells and NK cells in routine fetal 
thymic organ cultures (mFTOC) and in vitro clonogenic assays. CD34 + TN thymocytes, the 
majority of which express  prominent cytoplasmic CD3e  (cytoCD3e) protein,  can be divided 
into  high  (CD34B~ig  ht)  and  low  (CD34 Dim) surface  expressing  populations.  CD34B~s  h'  TN 
thymocytes were capable of differentiating into T and NK cells when transferred into mFTOC, 
and demonstrated high NK cell clonogenic capabilities  when cultured in interleukin (IL)-2, IL- 
7,  and stem cell factor (SCF). Likewise, CD34B~ig  ht TN thymocyte clones after 5 d in culture 
were capable of generating NK and T  cells when transferred into mFTOC but demonstrated 
clonogenic NK cell differentiation capabilities  when maintained in culture with IL-2. CD34 Dim 
TN thymocytes, however, possessed only T cell differentiation capabilities in mFTOC but were 
not  expandable  in  clonogenic  conditions  containing  IL-2,  IL-7,  and  SCF.  No  significant 
differentiation of other cell lineage was detected in either mFTOC or in clonogenic assays from 
CD34 + TN thymocytes. These results represent the first definitive evidence of a common T/NK 
cell progenitor in the human fetal thymus and delineate the point in thymocyte differentiation 
where T  and NK cells diverge. 
N 
'K cells are a subset oflymphocytes distinct from T and 
B cells. Although NK cells do not express a CD3/TCR 
complex or rearrange the TCR genes, they share several char- 
acteristics with T cells including the expression of cytoplasmic 
CD3 proteins and numerous cell surface antigens (1, 3). These 
similarities have led to the hypothesis that NK cells may be 
related to T cells and thus may share a common progenitor. 
Indeed, it has been shown that routine triple negative (TN) 1 
thymocytes can give rise to T, as well as NK cells, in vivo 
(2, 4). However, the identification of a common T/NK cell 
progenitor remains elusive,  since these studies did not em- 
ploy clonal cell differentiation assays. 
Thymic T cell progenitors capable of reconstituting thymic 
organ cultures are contained within the TN thymocyte  popu- 
lation (5). Recently, we have demonstrated that human fetal 
TN thymocytes can be subdivided into two distinct subsets: 
CD34-  TN thymocytes which proliferate and generate NK 
1 Abbreviations used in thispaper: cytoCD3e, cytoplasmic CD3e; mFTOC, 
murine fetal thymic organ culture; SCF, stem cell factor; TN, triple negative. 
cells in the cloning conditions optimal for the growth of ma- 
ture NK and T  cells but that were unable to reconstitute 
T cell differentiation in murine fetal thymic organ cultures 
(mFTOC); and CD34 + TN thymocytes which would not 
generate NK cells in cloning conditions but readily recon- 
stituted T cell differentiation in mFTOC (6).  The presence 
of mature NK cells and committed NK cell precursors in 
the fetal thymus suggested that a certain degree of NK cell 
differentiation may occur in the thymus from progenitors that 
can give rise to both T and NK cell lineages.  In this study, 
we have examined whether human fetal CD34 + TN thymo- 
cytes contain a bipotential progenitor population capable of 
both T  and NK cell differentiation. 
Materials and Methods 
Cell Preparations.  Fetal  thymic and liver tissue were obtained 
from elective therapeutic abortions and used with the approval of 
the Ethical Committees of our Institute and Advanced Bioscience 
Resources, Inc. (Alameda, CA) from which the tissues were ob- 
tained. Gestation age was determined by crown ramp length and 
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fetal liver by standard Picoll-Hypaque procedures, followed by mag- 
netic bead depletion of erythroblasts (glycophorin A positive cells), 
as previously described (7). Thymocyte cell suspensions were pre- 
pared as previously described (6). 
rnAh  mAbs against the following antigens were used: CDla 
(T6; Coulter, Hiahah, FL); CD2 (Leu-5b); CD3 (Leu-4, UCHT1); 
CD4 (Leu-3a+b, L77, A-40); CD5 (Leu-1, UCHT2); CD7 (Leu- 
9);  CD8  (Leu-2a, RPA-T8); CD13  (Leu-M7); CD14  (Leu-M3, 
63D3); CD16 (Leu-11a); CD19 (Leu-12, B43); CD28 (L293); CD33 
(Leu-M9); CD34 (HPCA-2); CD38 (Leu-17); CD45 (HLE, H130); 
CD45tLA (Leu-18); CD56 (Leu-19 and L185); and glycophorin A 
(10F7Mn; American Type Culture Collection, Gaithersburg, MD). 
mAbs  were  generously  provided  by  Becton  Dickinson  Im- 
munocytometry System (San Jose, CA) or purchased from Phar- 
mingen  (San Diego,  CA) unless otherwise  indicated. 
Immunofluorescence,  Flow Cytometry, and Cell Sorting.  Methods 
of immunofluorescence staining and cell sorting have been described 
previously (6-8). Enrichment  of selected thymic populations was 
performed by incubation with specific mAb followed by magnetic 
bead depletion (Dynal, Inc., Oslo, Norway), as previously described 
(6, 9). Three-color immunofluorescence was performed with PE, 
FITC, and Cy-chrome  TM (Pharmingen) fluorochrome-conjugated 
mAbs,  followed  by  flow  cytometric  analysis.  Appropriate 
fluorochrome-conjugated  isotype-matched control  Igs were used 
in  all  experiments.  For  cell sorting,  thymocytes  were depleted 
of CD4 §  CD8 +,  and glycophorin  A + cells by magnetic  bead 
treatment.  Three-color  cell sorting  was performed by excluding 
Cy-chrome  TM positive cells. Cy-chromeTM-conjugated anti-CD3, 
-CD4, -CD8, -CD14, and -CD19 mAbs were used in all cell sorting 
experiments  to prepare TN thymocytes. 
For detection of cytoplasmic CD3, viable cells were first surface 
stained with Cy-chromeTM-labeled  anti-CD45 and PE-labeled anti- 
CD34 mAbs, fixed, and then incubated with FITC-labeled anti- 
CD3e mAb, as previously described (3). Leu 4 mAb was used to 
detect cytoplasmic CD3 proteins (7). The Leu 4 mAb recognizes 
CD3e protein only when associated with CD33, or CD3~ proteins 
(3,  10). 
Cloning of TN Thymic Populations.  TN thymocytes were cloned 
at one cell per well in Terasaki plates (Costar Corp., Cambridge, 
MA) using a single cell deposition system of the FACStar Plus  | 
flow cytometer (Becton Dickinson). Recombinant human IL-7 (100 
rig/m1) and human c-kit ligand (20 ng/ml) were purchased from 
K&D Systems (Minneapolis, MN), and recombinant human Ib2 
(100 U/ml) was produced at DNAX Research Institute  (kindly 
provided by Dr. Zurawski). Clones were established using Yssel's 
media (11) supplemented with 10% FCS (JR Scientific, Woodland, 
CA) and 2% human AB serum (Pel-Preez, Brown Deer, WI) sup- 
plemented  with the indicated factors. 
In some experiments, clones were initially established in IbT, 
stem cell factor (SCF), and 200 cells per well of an irradiated (5,000 
rad) melanoma cell line, MM170 (kindly provided by Dr. Hilary 
Warren, Woden Valley  Hospital, Canberra, Australia) without Ib2. 
These particular culture conditions were shown to give maximal 
clonal proliferation  of CD34  ~ght TN thymocytes in short  term 
culture (5 d) without NK cell differentiation. After 5 d in culture, 
"~25 cells from each of the most rapidly growing 40-60 clones were 
pooled and used to reconstitute a single murine thymic organ. The 
remaining cells of each clone were then fed with IL-2-containing 
media and culture for 4 wk. In some experiments, irradiated allo- 
genic PBMC, JY (B-LCL), IL-2 (100 U/ml), and PHA (0.1 ng/ml) 
(Ib2 stimulation conditions) were used as previously indicated (6, 
11). Growth of dendritic and myeloid cells from progenitor thymic 
populations was performed according to previously published pro- 
tocols (12, 13). 
Cell-mediated Cytotoxicity.  Cytotoxic activity was measured in 
a  standard 4-h  SlCr radioisotope  release assay (14) using  NK- 
sensitive K562 (erythroleukemia) and Jurkat (T cell leukemia) cells 
as targets. 
Thymic Organ Culture.  The human-mouse FTOC system was 
used as previously described (6, 15). Deoxyguanosine (dGu) (Sigma 
Chemical Co., St. Louis, MO)-treated  mouse thymic lobes were 
cocultured with sorted human thymic TN cell populations (1,000 
cells per lobe) for 10-20 d in IMDM (GIBCO BRL, Gaithersburg, 
MD), containing 2% human AB serum. After culture, thymic lobes 
were homogenized in PBS and phenotypic analysis was performed. 
Cy-chromeTM-conjugated anti-human  CD45 mAb was used to 
identify human  cells. In some experiments,  fetal murine  thymic 
lobes were reconstituted  with cells from pools of CD34  Bash' TN 
thymocyte derived clones as described in the previous section. These 
particular mFTOC were cultured for 10 d, homogenized, and then 
maintained in suspension culture for an additional 7 d in IL-2 stim- 
ulation  conditions. 
Results 
NK Cells Can Be Generated in a Thyraic Environment from 
CD34 +  Thymocyte  Progenitors.  TN  thymocytes  can  be 
divided into two subsets based on the expression of the he- 
matopoietic progenitor antigen, CD34. As we have recently 
reported,  CD34-  TN thymocytes are composed primarily 
of mature NK cells and NK cell committed precursors, whereas 
CD34 + TN  thymocytes contain  transplantable  T  cell pro- 
genitors (6). Although CD34 + TN thymocytes can readily 
differentiate to T cells in mFTOC, we also observed the ap- 
pearance of a small percentage (2-6%) of mature NK cells 
(CD56 +, CD5-,  surface CD3-) in mFTOC reconstituted 
with CD34 § TN thymocytes (Fig.  1). NK cells present in 
mFTOC demonstrated  antigenic expression similar to NK 
cells present in freshly isolated fetal TN thymocytes (data not 
shown). Since we have previously demonstrated that thymic 
NK cells and committed NK cell precursors were unable to 
expand in mFTOC (6), the appearance of mature NK ceils 
in these mFTOC suggested that  a progenitor for NK cells 
was contained within  the CD34 + TN  thymocytes. 
Antigenic Phenotype of Fetal TN Thymocytes.  To identify 
a possible NK cell progenitor,  the CD34 + TN  thymocyte 
population was analyzed by three-color flow cytometry. As 
displayed in Fig. 1, fetal TN thymocytes demonstrated a tri- 
modal distribution of CD34 expression. The majority of TN 
thymocytes expressed low surface density CD34 (CD34I~m), 
while coexpressing high surface density CD5,  CD2, CDT, 
CD28,  and  CD38  antigens  (Fig.  2  A).  These  CD34 Dim 
thymocytes also expressed CD1, an antigen associated with 
thymic T  cell differentiation (5,  16). The antigenic pheno- 
type of CD34 Dim TN thymocytes was thus consistent with 
the hypothesis that these cells represented thymic T cell com- 
mitted progenitors.  TN  thymocytes also contained a small 
percentage (7-18%) of cells expressing high surface density 
CD34  (CD34Bnght). Unlike  the CD34 Dim thymocytes,  the 
CD34 Bright subset  displayed  a  more  immature  antigenic 
phenotype with variable expression of CD5,  CD2,  CD28, 
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Figure  1.  Generation  of T and NK cells from CD34  + TN fetal thymo- 
cytes in mFTOC. (A) Expression of CD34 on fresh fetal TN thymocytes. 
TN  thymocytes can  be  divided into CD34Nes  ~*iV~, CD34Di% and 
CD34Bris  ht  subsets. Sorted CD34  + TN  thymocytes (including both 
CD34 ~  and CD34Beg  ht subsets) were transferred into mFTOC, and after 
10 d in culture, were phenotyped for the expression of CD56 and CD5 
(B), CD8 and CD4 (C), and CD1 and CD3 (D) on gated human CD45 + 
cells. In this representative experiment, 4% of the cells were identified 
as CD56  +  , CD5- NK cells. The histogram of cells stained with control 
mAb is superimposed  over the histogram of cells stained with anti-CD34 
mAb (A). (B-D) Data are displayed as two-color contour maps divided 
into quadrants based on >95% of the cells residing in the lower left quad- 
rant after staining with isotype control mAbs. 
CD38,  and  HLA-DR.  The  CD34B~is  ht  TN  thymocytes, 
however, expressed high surface density CD7 (an antigen as- 
sociated with T  and NK cell lineages) (1,  17,  18),  and sur- 
prisingly,  also expressed surface CD13 and CD33 antigens 
(Fig. 2 A). It is generally believed that the expression of CD13 
and  CD33  on progenitor  populations  is indicative  of my- 
eloid/monocytic lineage commitment  (19,  20). 
The expression  of CD13 and CD33 antigens  on CD34"ns  ht 
TN thymocytes raised the possibility that these thymocytes 
may represent a muhipotential hematopoietic stem cell popu- 
lation (16, 21-23). To address this question, TN thymocytes 
were  analyzed  for  the  expression  of  cytoplasmic  CD3e 
(cytoCD3e) protein. CytoCD3e expression is unequivocally 
restricted to cells committed to the T  and NK cell lineages, 
and has never been reported in the B cell or myeloid differen- 
tiation pathways (7, 24). Fig. 2 B clearly demonstrates that 
the majority of CD34 expressing TN  thymocytes contain 
high levels of cytoCD3e, as detected with the Leu-4 mAb, 
indicating their commitment to the T and/or NK cell lineages. 
Previous studies (3, 10) have shown that the Leu-4 anti-CD3 
antibody recognizes CD3~ protein only when complexed with 
CD3y and/or CD3<3 proteins. The CD34 + TN thymocytes 
thus express multiple components of the CD3 complex. In 
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contrast, the majority of CD34 § fetal liver cells did not con- 
tain cytoCDe (Fig.  2 B). These observations are consistent 
with the fetal liver being the primary site of fetal erythroid 
and myeloid differentiation.  It is interesting  to note that  a 
small  percentage  (<0.5%)  of fetal  liver  CD34 +  cells  ex- 
pressed cytoCD3e (Fig.  2 B). These CD34 + fetal liver cells 
expressing cytoCD3e may represent prethymic T and/or NK 
cell committed  progenitors. 
Identification of a T/NK  Thymic Progenitor Population.  Al- 
though  several  antigens  were  expressed  differentially  on 
CD34 Dim and CD34Brig  ht TN thymocytes (Fig.  2),  CD5 is 
an antigen  expressed on all  stages of T  cell differentiation 
and has never been reported on mature NK cells or NK cell 
precursors  (1,  6,  7).  We examined whether  the expression 
of CD5  may discriminate  CD34 §  TN  progenitors  com- 
mitted on the T  cell lineage.  To determine the capacity of 
various CD34 § TN  thymocyte populations  to generate T 
and NK cells in mFTOC, TN thymocytes were subdivided 
according to the expression of CD34 and CD5 antigens (Fig. 
3 A).  Three  populations  of TN  thymocytes (I-CD34 Dim, 
CD5 + ;  II-CD34Bns  ht,  CD5 + ;  and  III-CD34Bns  ht,  CD5-) 
were sorted to >96% purity and transferred into mFTOC. 
After 14-20 d in culture, the lobes were dissociated and ana- 
lyzed for the expression of the T cell-associated antigens, CD3, 
CD5, CD4, and CD8 and the appearance of mature NK cells 
(CD56 +, CD5-,  surface CD3-). Lobes reconstituted with 
CD34  Dim, CD5 + TN thymocytes were ef~cient progenitors 
for T cells in mFTOC (Fig. 3). The majority of cells in these 
lobes expressed surface CDS, CD4, CD8 (>95%), and CD3 
(60-70%),  antigens characteristic of normal T cell develop- 
ment (5, 25). In most experiments, NK cells were undetect- 
able in mFTOC  reconstituted with CD34 Dim, CD5 § pro- 
genitors (Fig.  3, B and C). In contrast,  the CD3@~g  h' TN 
thymocyte subset, regardless of the expression of CDS, was 
capable of generating both T and NK cells in mFTOC (Fig. 
3, D-G). Phenotypically mature NK cells represented 8-33% 
of the human CD45 § cells in mFTOC reconstituted with 
CD34 B~sh' TN  progenitors.  NK cells developing in  these 
mFTOC were indistinguishable from endogenous thymic NK 
cells, substantiating the hypothesis that the thymic microen- 
vironment can support the differentiation of NK cells.  He- 
matopoietic cells of other lineages,  such as B cells (CD19 § 
or monocytes (CD14+),  were not observed in these recon- 
stituted  mFTOC. 
Clonogenic  Potential  of  CD34 +  Thymocytes.  Although 
CD34B~ig  ht TN thymocytes can readily generate T  cells and 
NK cells in mFTOC, these experiments were not performed 
using single cell reconstitution.  Since transfer of 1,000 cells 
was required for consistent reconstitution,  it can be argued 
that  the CD3@ng  ~t subset may contain  unique  T  and NK 
cell committed progenitors and not a single bipotential pro- 
genitor. To address this question, we developed optimal in vitro 
single cell cloning conditions for CD3@'ig  ht TN thymocytes 
using IL-2, IL-7, and SCF as growth factors. Cloning e~cien- 
cies of 70-95%  were consistently observed (Table 1).  It is 
interesting that these cloning conditions did not support the 
clonal  expansion  of CD34 Dim TN  thymocytes,  thymic  T 
cells, thymic NK cells, or mature peripheral blood NK cells. 0 
A 
o 
r 
6  0  8 
8 
I  r 
8 
0 
.... i~  .....  i~]  ii 
￿9  CD34 
.B  ,  ,  .  L  Fetal  liver  ￿9  I  thymus 
o 
CD34 
Figure 2.  Antigenic  phenotype  of fetal  CD34  + TN thymocytes.  (A) Freshly  isolated  fetal  TN thymocytes  were stained  with Cy-chrome-conjugated 
anti-CD45 mAb, FITC-conjugated  anti-CD34 mAb, and PE-conjugated  mAbs against  various  leukocyte  antigens.  (B) TN thymocytes  and T cell-depleted 
fetal liver cells were analyzed for the coexpression of surface CD34 and cytoCD3e antigens on CD45 § gated cells. 
Cloning conditions which we have previously shown to be 
optimal for the cloning of mature NK and T cells (11) were 
also unable to support the clonal expansion of CD34 + TN 
thymocytes. After 3 mo in culture, clones derived from the 
CD34Bris  ht, CD5 +, and the CD3@'is  ht, CD5-  subsets had 
expanded sufficiently to allow for analysis of function, anti- 
genic phenotype and TCR gene rearrangement. All clones 
derived from the CD34B"s  h' TN thymocyte subset displayed 
a typical NK cell antigenic phenotype, with high surface den- 
sity CD56 expression and no detectable surface CD3 or CD5 
antigens (Fig. 4, C and E). Consistent with their antigenic 
phenotype, these clones demonstrated strong cytolytic  activity 
against NK-sensitive targets, K562 and Jurkat (Fig. 4, D and 
F). Since NK cells are also defined by their lack ofTCR gene 
rearrangements,  100 individual clones derived from CD34S~  ht 
TN thymocytes were combined into 10 pools and analyzed 
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Figure  3.  Antigenic phenotype of human thy- 
mocytes recovered from mFTOC. TN thymocytes 
were stained with FITC-conjugated anti-CD34 and 
PE-conjugated anti-CD5 mAbs and sorted (>97% 
purity)  into  three  subsets:  I-CD34  Dim, CD5+; 
II-CD34B~ ht, CD5 +; and III-CD34Bnght, CD5-. 
(A) Each sorted subset was cultured in mFTOC 
for 15 d.  (/3 and C) Expression of CD56, CD5, 
CD4, and CD8 on cells recovered from mFTOC 
reconstituted  with  I-CD34  Dim,  CD5 +  TN 
thymocytes. Approximately 98% of the cells ex- 
pressed CD5, whereas <2% were CD56 +, CD5- 
NK calls. (D and E) Expression of CD56, CD5, 
CD4, and CD8 on calls recovered from mFTOC 
reconstituted  with  II-CD34B~ig  ht,  CD5 +  TN 
thymocytes. 25% of the cells in these mFTOC were 
phenotypically  CD56 +, CD5-  NK calls. (F and 
G) Expression  of CD56, CD5, CD4, and CD8 
on cells recovered  from mFTOC reconstituted with 
III-CD34Bas  h~, CD5-  TN thymocytes.  29%  of 
the cells in these  mFTOC were phenotypically 
CD56 +, CD5- NK cells. These resuhs at day 15 
are representative of four different experiments in 
which 8-33%  of the CD45 + cells in mFTOC 
reconstituted  with  CD34Brig  ht  thymocytes  were 
NK cells. Similar percentages of NK cells were ob- 
tained  from lobes  seeded with  CD34Bn8  ht  cells 
regardless of expression  of CD5. 
by Southern blot for TCR gene rearrangements. No evidence 
of TCR Cfl or J3' rearrangement was observed in any of these 
clones (data not shown). Likewise, these NK clones did not 
differentiate into T cells when transferred into mFTOC (data 
not shown). 
Generation of NK and T  Cells from Bipotential CD34B"e  ht 
TN Thymocytes Clones.  Although CD34 B~ight TN thymo- 
cytes displayed high NK cell clonogenic frequencies, it can 
be argued that the progenitors responsible for reconstituting 
T cell differentiation  in mFTOC were contained in the 5-30% 
Table  1.  Frequency  of Clones Obtained  from Thymic Populations 
Cell 
population 
Cloning efficiency 
Irradiated  PBMC + JY + 
IL-2 + IL-7 + SCF  IL-2 + PHA 
% 
CD34 +  + 5 -  70-95  (90)*  0 
CD34 +  + 5 +  70-95  (88)  0 
CD34 + 5 +  0  0 
TN thymocytes were cloned  as indicated  in Fig. 4. 
* Cultures supplemented with indicated factors (refed weeldy) were scored 
for wells containing >1,000 cells over a 4-wk culture period. Phenotypic 
and functional  analysis were performed after 3 mo in culture. All clones 
displayed a typical NK cell antigenic phenotype (CD56+CD3-).  Values 
represent the ranges and means (in parentheses) of three to six experiments. 
of the CD34 Bright TN thymocytes that did not generate NK 
clones in clonogenic assays. To directly analyze the bipoten- 
tial differentiation  capacity of CD34 B~ight TN  thymocytes, 
CD34Brig  ht TN thymocytes were cloned in IL-7, SCF, and 
an  irradiated  melanoma  cell line,  MM170  as  described in 
Materials  and Methods.  In preliminary  experiments,  these 
conditions were shown to induce maximum proliferation in 
short-term cultures, while delaying commitment to the NK 
cell lineage. After 5 d in culture, "~25 cells from each of the 
most rapidly growing clones were pooled and used to recon- 
stitute a single fetal routine thymic organ. Since it was neces- 
sary to pool clones in order to obtain enough cells to recon- 
stitute the mFTOC ("~1,000 cells per lobe), it was critical 
that 100% of the clones employed in reconstituting the fetal 
thymic lobes were expandable and showed NK cell differen- 
tiation capacity.  As displayed in Fig. 5 A, 100% of the clones 
demonstrated  a typical NK cell antigenic phenotype, with 
high surface density CD56 and no detectable surface CD3 
or CD5.  The mFTOC reconstituted with the clones were 
cultured for 10 d, homogenized into single cell suspensions, 
and cultured an additional 7 d in IL-2 stimulation conditions 
(optimal for expansion of mature T and NK cells). Ahhough 
the T  cell reconstitution capabilities of short-term cultured 
CD34 Bright TN thymocyte clones was relatively poor,  anti- 
genic phenotype of these cultures clearly demonstrated the 
appearance  of mature  CD3 +  T  cells  as  well  as  CD56 +, 
CD3-  NK ceils (Fig.  5 B). These results present strong evi- 
dence for a common T/NK cell progenitor, since the T cells 
in these mFTOC were derived from clones that demonstrated 
100%  NK cell differentiation  capabilities. 
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Figure 4.  NK  clones  derived 
from CD34 § TN thymocyte  sub- 
sets. CD34  ~  CD5 +; CD34~'ig  ht, 
CD5 +  ; and CD34S~  t, CD5 -  TN 
thymocytes were single cell cloned 
into Terasaki plates and cultured for 
3 mo (A). No clones were obtained 
from  CD34  Dim, CD5 +  TN  thy- 
mocytes (B). All clones derived from 
CD34~q% CD5 +  ; and CD34~ht, 
CD5-  TN thymocytes  were NK 
cells expressing high surface density 
CD56 without surface  CD3 expres- 
sion (C and E). Cytolytic function 
of NK clones against the K562 (open 
bars) and Jurkat (closed  bars)  targets 
(D and F). Data from three repre- 
sentative clones are shown at an E/T 
ratio  of 3:1. 
Discussion 
Recent studies (2, 4) in the mouse have suggested the ex- 
istence of a bipotential T/NK cell progenitor in the thymus, 
capable of generating T and NK cells in vivo. These studies, 
however, were unable to determine if there exists a common 
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Figure  5.  Generation  of NK and T cells from CD34 § TN thymocyte 
clones. CD34Brig  ht TN thymocytes  were single cell cloned and cultured 
in II.-7, SCF, and the human  melanoma  cell line, MM170.  After 5 d in 
culture, ,'~25 cells from each of the most rapidly growing clones were pooled 
and used to reconstitute a single fetal murine thymic organ. The remaining 
cells from each clone were grown in IL-2-supplemented  cloning media 
T/NK progenitor due to the inability to analyze the progen- 
itor populations at the clonal level from freshly isolated cells. 
The data in the present report clearly demonstrate that in 
the  human  fetal  thymus the  CD34~i~ h~ TN  thymocytes 
possess  high NK cell clonogenic frequencies and NK and T cell 
reconstitution capabilities in mFTOC. Likewise, CD34Bng  at 
TN thymocyte derived clones, before commitment to the NK 
cell lineage, can differentiate into T cells in mFTOC. These 
observations  support  the  hypothesis that  CD34Bns  ht  TN 
thymocytes are bipotential progenitors for T and NK cells. 
In contrast, the CD34  Dim TN thymocytes, the majority of 
which coexpress CD1, are T cell-committed progenitors in- 
capable of differentiation towards the NK cell lineage. There- 
fore the expression of CD1 on thymocytes may serve as an 
important cell surface marker indicating irreversible T  cell 
commitment (5). By contrast, the expression  of CD5, al- 
though a molecule acquired during thymic differentiation, 
clearly does not indicate irreversible  T cell lineage commitment. 
Our results suggest that the earliest T/NK committed pro- 
genitor in the fetal thymus expresses  high surface  density CD34 
for 4 wk and phenotyped  for the expression of CD56 and CD3 surface 
antigens  (,4).  The  reconstituted  mFTOC  was  cultured  for  10  d, 
homogenized, cultured an additional 7 d as previously described, and pheno- 
typed for CD56 and CD3 surface antigens  (B). (tl) Representative  NK 
cell antigenic phenotype from 1 of 60 clones used to reconstitute a mFTOC. 
All clones displayed an identical NK cell antigenic phenotype with high 
surface density CD56 and no detectable surface CD3. (B) Antigenic pheno- 
type of cultured  mFTOC cells demonstrating both NK cells (CD56 +, 
CD3-; 88%) and T  cells (CD56-, CD3+; 12%).  Similar results were 
obtained from two additional lobes. The data are displayed as two color 
contour maps divided into quadrants based on >95% of the cells residing 
in the lower left quadrant  after  staining  with isotype  control mAbs. 
574  Common T/NK Cell Progenitor TCR GENE 
REARRANGEMENT 
STEM  T/NK BIPOTENTIAL  \  /  COMMITTED  MATURE 
CELL  THYMOCYTE  ,~l  THYMOCYTE  THYMOCYTES 
PROGENITORS  PRECURSORS 
@-@  @-@ 
C034++  CD7•  C034+§  CDT++  CD34§  CO7+  CD34-  COl*  CO34-  CO7§ 
CD33§  CD2-  CD33+§  CD2•  CD33-  CD2+  CD33-  CD2+  CD33-  CD2+ 
CD13++  CDw  CD13++  C05•  CD13+  CDS+  C013-  CD5+  CD13-  C05+ 
CD3E-  C028-  CD38~§  CO28•  CD38++  CO28+  CD38++  C028+  CD38++ CD28§ 
HLA DR-  COl-  HLA OR~ CO1"  HLA DR"  COl+  HLADR-  CDI+  HLA DR-  CDt- 
CD3-4•  CD3-4+8+  CD3§ 
C03§  C03+4-8+ 
CD3+4-8" 
￿9  @ 
CD34-  CDT+  CD34-  CDT§ 
CD33-  CD2•  CD33-  CO2• 
CD13-  CDS-  CD13-  CD5- 
C038++  CD28-  CD38++  CO28- 
HLA DR-  CD1-  HLA OR-  CD1- 
C056-  C056+ 
C016-  CD16• 
I 
MATURE 
T CELLS 
MATURE 
NK CELL 
Figure  6.  Model of fetal thymocyte development. 
Hypothetical fetal  thymic  stem  cell  (<1%  of TN 
thymocytes) express high levels of CD34, CD13, and 
CD33  antigens.  Commitment  of  the  pluripotent 
CD34 + +, CD13 + +, and CD33 + + cells toward the 
T/NK cell lineage induces the expression of cytoplasmic 
CD3 proteins (cCD3) and CD7. Under the influence 
of the thymic environment, CD2, CD5, and CD28 
are subsequently expressed on the bypotential T/NK 
progenitor. Downregulation of CD34,  CD13,  and 
CD33 followed by expression of CD1 and TCK gene 
rearrangement indicates  irreversible commitment to 
the T  cell lineage. CD1 + T cell progenitors prefer- 
entially expand (thick arrow) and further mature in the 
thymus. Limited intrathymic NK cell differentiation 
results in the downregulation of CD34, CD13, CD33, 
CD5, CD28, and cCD3 and the progressive acquisi- 
tion of NK cell-associated  markers. Pluripotent stem 
cells (open circle), bipotential progenitor cells (low den- 
sity dashed circle), lineage committed ceils (high density 
dashed circles). 
antigen and cytoCD3e. It is interesting to note that we have 
identified a small subset of fetal liver cells displaying these 
characteristics (Fig.  2 B).  These CD34 +, cytoCD3e + cells 
may represent a population of prethymic T/NK progenitors. 
Recent  reconstitution  studies  employing SCID  mice  and 
human thymic organ cultures have demonstrated that fetal 
liver contains transplantable T cell progenitors (13, 26). Fur- 
ther studies of the fetal liver CD34 +, cytoCD3e population 
are required to determine the T/NK progenitor capabilities 
of these cells. 
Previous studies (27) have suggested that the human thymus 
may contain hematopoietic stem cells, capable of muhilineage 
differentiation. Most CD34Bns  ht TN thymocytes are clearly 
not multipotential stem cells, particularly since the majority 
of these cells express high levels of cytoCD3e protein, an un- 
equivocal marker for T cell and/or NK cell lineage commit- 
ment (3, 7, 24).  Consistent with these findings, it was re- 
cently  shown  that  CD34 §  CD7 +  TN  thymocytes  are 
incapable of monocytic/myeloid differentiation (28). It is pos- 
sible,  however,  that  a  small percentage of CD34Bns  h' TN 
thymocytes (<2% of CD34 expressing cells) that do not ex- 
press cytoCD3e  protein may represent uncommitted mul- 
tipotential progenitors. Indeed, in preliminary experiments 
we have observed that, under appropriate in vitro clonal con- 
ditions  (12,  13),  CD34 B~gh' TN  thymocytes can generate 
myeloid CFUs and dendritic-like cells with a very low cloning 
frequency <2%  (data not shown). 
The identification of a bipotential T/NK cell progenitor 
in the fetal thymus establishes a direct lineage relationship 
between the T  and NK cell differentiation pathways. Based 
on our observations and others, we propose that CD34Bng  h~, 
cytoCD3e expressing TN thymocytes are a relativdy homog- 
enous population of bipotential T/NK cell progenitors. Under 
the influence of the thymic microenvironment, these pro- 
genitors gradually acquire surface CD2, CD5, CD28, CD38, 
and eventually CD1 antigens (Fig. 6). As these antigens in- 
crease in surface density, CD34 is concurrently downregu- 
lated and these progenitors become irreversibly committed 
to the T cell lineage, presumably at the onset of TCK rear- 
rangement. We predict that the initiation of TCR rearrange- 
ment occurs during the transition from CD1-  to CD1 + in 
TN thymocytes. Before the expression of CD1,  CD34B"g  ht 
TN thymocytes have the potential to differentiate towards 
either the T  or NK cell lineages. Ahhough the majority of 
thymic progenitors are destined for commitment to the T 
cell lineage, a small percentage of these bipotential progen- 
itors differentiate into committed NK cell precursors and ma- 
ture NK cells within the microenvironment of the thymus. 
The immunological significance of thymic NK cell differen- 
tiation is at present unknown. Mature NK cells, however, 
are detectable in the embryonic liver as early as 6 wk gesta- 
tion, which is substantially earlier than the formation of the 
thymus anlage (7).  It is possible, therefore, that before the 
development of the thymic microenvironment, putative T/NK 
progenitors in fetal liver are directed towards the NK differen- 
tiation pathway. The signals which direct these bipotential 
progenitors towards T and/or NK cell differentiation pathways 
are at present unknown.  The identification of a common 
T/NK cell progenitor in the thymus, however, will greatly 
facilitate our understanding the biochemical and molecular 
mechanisms that direct the divergent lineage differentiation 
of NK  and T  cells. 
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